GI Flashcards
N/V Gastroenteritis or Drug PATHWAY
CTZ
Receptors: Serotonin & Dopamine
N/V Gastroenteritis or Drug PATHWAY TREATMENT
Top choices:
Dopamine receptor: promethazine»_space; inexpensive, EPS SEs
Serotonin receptor: generic, still expensive
other options: antihistamines
N/V Motion Sickness PATHWAY
Vestibular pathway
Receptors: Acetylcholine-muscarinic, histamine
N/V Motion Sickness PATHWAY TREATMENT
First line:
Antihistamines»_space; sedation
Anticholinergics (antimuscarinics)»_space; CAN’T SEE, PEE, SPIT, SHIT
N/V Emotional/Anticipatory PATHWAY
Limbic system
Receptors: GABA, histamine
N/V Emotional/Anticipatory PATHWAY TREATMENT
Benzodiazepines: INC activity of GABA, an inhibitory neurotransmitter
Antihistamines: Hydroxyzine DOC for its antiemetic/sedating properties
Patient-specific treatment: PONV
5 HT3 blocker
phenothiazine
NK1 receptor blocker
Patient-specific treatment: PEDs
Phenothiazine
Antihistamine/Anticholinergic
Patient-specific treatment: PREGNANCY
Antihistamine/Anticholinergic
5 HT3 blockers: controversial
Promethazine: controversial
Patient-specific treatment: CIINV
5 HT3 blockers
NK1 receptor blockers
Cannabinoid
Benzodiazepine
Corticosteroid
Metoclopramide
Phenothiazines
Antihistamines
TREAT THE CAUSE
N/V is a SYMPTOM
most of the time, it is self-limiting = resolve on its own
newborn = congenital obstruction
infant = obstructive lesions, metabolic disease, nutrient intolerance
children/adolescents/adults = drug induced; metabolic disorders; GI disorder; Motility disorder; Acute abdomen; Infection of abdomen; CV disease; Neurological process; emotional
Phenothiazines MOA/USES
oldest
(-zine) = promethazine (phenergan) and prochlorperazine (compazine)
MOA: block dopamine in CTZ; block cholinergic, alpha1-adrenergic, histamine receptors in vomiting center
monotherapy in mild - mod nausea, or combo for severe nausea
block nausea from blood and CSF: pathogenic toxins, opiates, to much body electrolytes, partying, GI bug, trauma
Phenothiazines ADVANTAGES/DISADVANTAGES
ADVANTAGES:
inexpensive, except SR form
variety of forms
viable and practical option for LONG-TERM USE
DISADVANTAGES:
causes sedation»_space; CAUTION w/ CNS depressants
Preg C
NO anticonvulsants, Coumadin
Phenothiazines AEs
SAME AS ANTIPSYCHOTICS
Extra-pyramidal sx: tremors, tardive dyskinesia, dystonia
CONTRAINDICATED: Parkinson’s
AE: sedation, resp depression (NO children <2, elderly start low dose, resp disorders)
may suppress cough reflex
anticholinergic effects: dry mouth, dry eyes, blurred vision, urinary retention, urine color change
Antihistamines-Anticholinergics MOA/USES
MOA: block histamine and cholinergic receptors along vestibular pathway and in vomiting center
antihistamines: block H1 receptors, bind to central cholinergic receptors responsible for N/V
anticholinergics: DEC secretion of saliva and GI motility
BLOCK N/V originating from inner ear»_space; motion sickness, vertigo
motion sickness: take 30-60 min before event
patch: apply 1-2 hrs before event and may reapply q3 days
Antihistamines-Anticholinergics MEDS
dimenhydrinate (dramamine)»_space; Pre B
Diphenhydramine (benadryl)»_space; Preg B
Hydroxyzine (vistaril, atarax)
meclizine (antivert)
scopolamine
trimethobenzamide (tigan)
Antihistamines-Anticholinergics Contraindications
Antihistamines: CAUTION asthma, glaucoma, GI/GU obstruction
NO LACTATION
Anticholinergics: CAUTION: glaucoma, bladder neck obstruction, GI obstruction
Antihistamines-Anticholinergics AEs
Antihistamines: sedation, drowsiness, confusion
Anticholinergics: CAN’T SEE, PEE, SPIT, SHIT
mydriasis, blurred vision, urinary retention, dry mouth, constipation
Benzodiazepines MOA/USES
MOA: blocks signals from limbic system from reaching vomiting center
usually used in combo w/ other agents for CINV
USES: N/V and provide an anxiolytic and amnesic effect
most beneficial w/ anticipatory N/V
Benzodiazepines DOC/Contraindications/AEs
DOC: Lorazepam
Preg D
CONTRAINDICATIONS: hepatic/renal failure
AE: CNS depression, paradoxical CNS stimulation
**MONITOR LFTs before dosing
Serotonin Receptor Blockers MOA/USES
MOA: block 5HT3 receptors (many in GI tract)
USES: initially for CINV, but expanded to radiation induced N/V and PONV
Serotonin Receptor Blockers AEs
oral administration encouraged
Preg B
AE: few
HA, fatigue, dizziness, constipation, pruritis, fever
Cannabinoids
MOA: unknown
does NOT involve CTZ
AE: sedation, ataxia, dysphonia, may develop tolerance to most AEs w/ repeated dosing, but NOT antiemetic effect
Appetite stimulant»_space; the munchies
Cannabinoids Routes PROBLEMS
Smoking: works like PCA, risk of high THC levels producing AEs
Vaporizing: patient control intake, risk HIGH initial blood levels, NOT easily nebulized, coughing/irritation
oral: predictable onset, absorption rate variable, first-pass effect; difficult to titrate optimum dose
sublingual: patient controlled, rapid onset, less AEs, ONLY IN UK
NK1 Receptor Antagonists
newest
aprepitant (emend)
Crosses BBB to occupy NK1 receptors
MOA: inhibit substance P from binding to NK1 receptor = no N/V
augment activity of 5HT3 receptor blockers
NK1 Receptor Antagonists AEs
AE: fatigue, dizziness, hiccups, **elevated LFTs
CYP3A4 inducer
**can cause life threatening reactions when combined w/ certain drugs
N/V Other Meds
Metoclopramide: A Prokinetic
Corticosteroids: used for CINV
MOA: unknown
BEWARE GI irritation, Hyperglycemia
AE: steroid psychosis, HA, insomnia, glucose intolerance»_space; long-term use
Antacids: coat the stomach or neutralize acid
GERD Patho
relaxed LES or cardiac sphincter allows contents to be splashed into esophagus
ACID burns esophageal tissue
GERD Causes
GERD Risk Factors